Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

ClinicalTrials.gov ID: NCT01947608

Public ClinicalTrials.gov record NCT01947608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Novartis-sponsored, open-label, multi-center, interventional ETP to provide LDK378 to patients with ALK (+)NSCLC, who have been pre-treated with an ALK inhibitor; except in countries where ALK inhibitors are not approved or available. The protocol will further evaluate the safety of LDK378 in patients with ALK(+) NSCLC.

Study identification

NCT ID
NCT01947608
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Nov 3, 2020

United States locations

U.S. sites
27
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Ironwood Cancer and Research Centers Chandler Arizona 85224 —
Banner MDACC Gilbert Arizona 85234 —
Western Regional Medical Center, Inc. Goodyear Arizona 85338 —
Highlands Oncology Group Fayetteville Arkansas 72703 —
City of Hope National Medical Center Duarte California 91010 —
Moores UCSD Cancer Center La Jolla California 92093 —
St Joseph Heritage Healthcare Santa Rosa California 94503 —
Stanford University Stanford California 94305-5203 —
Eastern Connecticut Hematology & Oncology Associates Norwich Connecticut 06360 —
Advanced Medical Specialties Miami Florida 33176 —
Peachtree Hematology/Oncology Consultants Atlanta Georgia 30309 —
Emory University School of Medicine/Winship Cancer Institute Atlanta Georgia 30322 —
Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Indiana University Health Goshen Center for Cancer Goshen Indiana 46526 —
Johns Hopkins Bayview Hospital Baltimore Maryland 21224 —
Maryland Oncology Hematology, P.A. Rockville Maryland 20850 —
Massachusetts General Hospital Mass General Boston Massachusetts 02114 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Jackson Oncology Associates Jackson Mississippi 39202 —
Nebraska Cancer Specialist/Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Mercy Clinic Oklahoma Communities Mercy Oncology Oklahoma City Oklahoma 73120-9391 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Tennessee Cancer Specialists Knoxville Tennessee 37909 —
University of Utah / Huntsman Cancer Institute Salt Lake City Utah 84112-5820 —
Seattle Cancer Care Alliance Seattle Washington 98109-1023 —
University of Wisconsin Madison Wisconsin 53705-2397 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01947608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2020 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01947608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →